- call +1-201-465-4211
- email sales@mrinsights.biz
The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.
Scope of the Report:
This report studies the Canine Stem Cell Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Canine Stem Cell Therapy market by product type and applications/end industries.
A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry.
The global Canine Stem Cell Therapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Canine Stem Cell Therapy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Allogeneic Stem Cells
Autologous Stem cells
Market Segment by Applications, can be divided into
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Canine Stem Cell Therapy Market Overview
1.1 Product Overview and Scope of Canine Stem Cell Therapy
1.2 Classification of Canine Stem Cell Therapy by Types
1.2.1 Global Canine Stem Cell Therapy Revenue Comparison by Types (2017-2023)
1.2.2 Global Canine Stem Cell Therapy Revenue Market Share by Types in 2017
1.2.3 Allogeneic Stem Cells
1.2.4 Autologous Stem cells
1.3 Global Canine Stem Cell Therapy Market by Application
1.3.1 Global Canine Stem Cell Therapy Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Veterinary Research Institutes
1.4 Global Canine Stem Cell Therapy Market by Regions
1.4.1 Global Canine Stem Cell Therapy Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Canine Stem Cell Therapy Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Canine Stem Cell Therapy Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Canine Stem Cell Therapy Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Canine Stem Cell Therapy Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Canine Stem Cell Therapy Status and Prospect (2013-2023)
1.5 Global Market Size of Canine Stem Cell Therapy (2013-2023)
2 Manufacturers Profiles
2.1 VETSTEM BIOPHARMA
2.1.1 Business Overview
2.1.2 Canine Stem Cell Therapy Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.2 Cell Therapy Sciences
2.2.1 Business Overview
2.2.2 Canine Stem Cell Therapy Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Regeneus
2.3.1 Business Overview
2.3.2 Canine Stem Cell Therapy Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Regeneus Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Aratana Therapeutics
2.4.1 Business Overview
2.4.2 Canine Stem Cell Therapy Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Aratana Therapeutics Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.5 Medivet Biologics
2.5.1 Business Overview
2.5.2 Canine Stem Cell Therapy Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Medivet Biologics Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Okyanos
2.6.1 Business Overview
2.6.2 Canine Stem Cell Therapy Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Okyanos Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Vetbiologics
2.7.1 Business Overview
2.7.2 Canine Stem Cell Therapy Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Vetbiologics Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.8 VetMatrix
2.8.1 Business Overview
2.8.2 Canine Stem Cell Therapy Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 VetMatrix Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.9 Magellan Stem Cells
2.9.1 Business Overview
2.9.2 Canine Stem Cell Therapy Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Magellan Stem Cells Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.10 ANIMAL CELL THERAPIES
2.10.1 Business Overview
2.10.2 Canine Stem Cell Therapy Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
2.11 Stemcellvet
2.11.1 Business Overview
2.11.2 Canine Stem Cell Therapy Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Stemcellvet Canine Stem Cell Therapy Revenue, Gross Margin and Market Share (2016-2017)
3 Global Canine Stem Cell Therapy Market Competition, by Players
3.1 Global Canine Stem Cell Therapy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Canine Stem Cell Therapy Players Market Share
3.2.2 Top 10 Canine Stem Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Global Canine Stem Cell Therapy Market Size by Regions
4.1 Global Canine Stem Cell Therapy Revenue and Market Share by Regions
4.2 North America Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
4.3 Europe Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
4.5 South America Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
5 North America Canine Stem Cell Therapy Revenue by Countries
5.1 North America Canine Stem Cell Therapy Revenue by Countries (2013-2018)
5.2 USA Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
5.3 Canada Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
5.4 Mexico Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
6 Europe Canine Stem Cell Therapy Revenue by Countries
6.1 Europe Canine Stem Cell Therapy Revenue by Countries (2013-2018)
6.2 Germany Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
6.3 UK Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
6.4 France Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
6.5 Russia Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
6.6 Italy Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Canine Stem Cell Therapy Revenue by Countries
7.1 Asia-Pacific Canine Stem Cell Therapy Revenue by Countries (2013-2018)
7.2 China Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
7.3 Japan Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
7.4 Korea Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
7.5 India Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
8 South America Canine Stem Cell Therapy Revenue by Countries
8.1 South America Canine Stem Cell Therapy Revenue by Countries (2013-2018)
8.2 Brazil Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
8.3 Argentina Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
8.4 Colombia Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Canine Stem Cell Therapy by Countries
9.1 Middle East and Africa Canine Stem Cell Therapy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
9.3 UAE Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
9.4 Egypt Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
9.6 South Africa Canine Stem Cell Therapy Revenue and Growth Rate (2013-2018)
10 Global Canine Stem Cell Therapy Market Segment by Type
10.1 Global Canine Stem Cell Therapy Revenue and Market Share by Type (2013-2018)
10.2 Global Canine Stem Cell Therapy Market Forecast by Type (2018-2023)
10.3 Allogeneic Stem Cells Revenue Growth Rate (2013-2023)
10.4 Autologous Stem cells Revenue Growth Rate (2013-2023)
11 Global Canine Stem Cell Therapy Market Segment by Application
11.1 Global Canine Stem Cell Therapy Revenue Market Share by Application (2013-2018)
11.2 Canine Stem Cell Therapy Market Forecast by Application (2018-2023)
11.3 Veterinary Hospitals Revenue Growth (2013-2018)
11.4 Veterinary Clinics Revenue Growth (2013-2018)
11.5 Veterinary Research Institutes Revenue Growth (2013-2018)
12 Global Canine Stem Cell Therapy Market Size Forecast (2018-2023)
12.1 Global Canine Stem Cell Therapy Market Size Forecast (2018-2023)
12.2 Global Canine Stem Cell Therapy Market Forecast by Regions (2018-2023)
12.3 North America Canine Stem Cell Therapy Revenue Market Forecast (2018-2023)
12.4 Europe Canine Stem Cell Therapy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Canine Stem Cell Therapy Revenue Market Forecast (2018-2023)
12.6 South America Canine Stem Cell Therapy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Canine Stem Cell Therapy Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Canine Stem Cell Therapy Picture
Table Product Specifications of Canine Stem Cell Therapy
Table Global Canine Stem Cell Therapy and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
